Hematopoietic Innovative Therapies

“CIEMAT’s Hematopoietic Innovative Therapies group is  focused on the development of translational research to improve the diagnosis and treatment of inherited and acquired pathologies through genetic, molecual and cellular biology techniques”

  • Foto1
  • Foto2
  • Foto3
  • Foto4
News Highlights

Fanconi Anemia

A gene therapy clinical trial for patients with Fanconi Anemia offers its first successful results

Dyskeratosis Congenita

A new cell model of dyskeratosis congenita will help understand the disease and evaluate new therapies

LAD-I immunodeficiency

First successful results in gene therapy in a patient with LAD-I immunodeficiency



Ir al portal web del Ciemat Portal web grupo Terapias Innovadoras Portal web CIBERER Portal web UE - Desarrollo Regional Portal web Instituto de Investigación Sanitaria